Immunohistochemical Evaluation of Ki-67 and Comparison with Clinicopathologic Factors in Breast Carcinomas
Conclusion: Ki-67 is
useful for treatment decisions in primary breast cancer patients. The high value of Ki-67 was associated with adverse
clinicopathologic factors. The increased Ki-67 value should be carefully investigated in triple negative patients.
PMID: 30678383 [PubMed - in process]
Source: Asian Pacific Journal of Cancer Prevention - Category: Cancer & Oncology Tags: Asian Pac J Cancer Prev Source Type: research
More News: Breast Cancer | Breast Carcinoma | Cancer | Cancer & Oncology | Carcinoma | HER2 | Hormones | Men | Menopause | Study | Tamoxifen